Financial Lp Hrt Purchases 27,993 Shares of NewGenIvf Group (NASDAQ:NIVF) Stock

NewGenIvf Group Limited (NASDAQ:NIVF) major shareholder Financial Lp Hrt purchased 27,993 shares of NewGenIvf Group stock in a transaction dated Tuesday, May 26th. The stock was acquired at an average cost of $0.92 per share, with a total value of $25,753.56. Following the completion of the acquisition, the insider directly owned 139,878 shares in the company, valued at approximately $128,687.76. This trade represents a 25.02% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Wednesday, May 27th, Financial Lp Hrt sold 85,317 shares of NewGenIvf Group stock. The shares were sold at an average price of $0.80, for a total value of $68,253.60.
• On Friday, May 22nd, Financial Lp Hrt acquired 137,541 shares of NewGenIvf Group stock. The stock was purchased at an average cost of $0.99 per share, with a total value of $136,165.59.

NewGenIvf Group Stock Up 21.2%

NASDAQ NIVF opened at $1.03 on Friday. NewGenIvf Group Limited has a 1-year low of $0.72 and a 1-year high of $1,839.00. The business has a 50 day moving average price of $1.66 and a 200 day moving average price of $6.74. The company has a quick ratio of 2.98, a current ratio of 3.12 and a debt-to-equity ratio of 0.16.

NewGenIvf Group (NASDAQ:NIVF) last released its quarterly earnings data on Tuesday, March 31st. The company reported ($287.24) earnings per share for the quarter. The company had revenue of $1.42 million during the quarter. As a group, analysts anticipate that NewGenIvf Group Limited will post 4.74 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of NewGenIvf Group in a research note on Monday, April 27th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.